Apigenin at high concentrations (>40 μM) induces apoptosis in leukemia cells and breast cancer cells and sensitizes the malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis (2–4). This evidence concerns the gene TNFSF10 and breast carcinoma.